Overview

Hydroxychloroquine in Cystic Fibrosis

Status:
Completed

Trial end date:
2007-12-01

Target enrollment:

Participant gender:

Summary

Study levels of inflammatory mediators in induced sputum of patients with cystic fibrosis before and after a 4 week course of oral hydroxychloroquine.

Phase:

Phase 1

Details

Lead Sponsor:

Vanderbilt University
Vanderbilt University Medical Center

Treatments:

Hydroxychloroquine